Cite
HARVARD Citation
Sands, B. et al. (n.d.). 14 POST-HOC ANALYSIS OF TOFACITINIB CROHN'S DISEASE PHASE 2 INDUCTION EFFICACY IN SUBGROUPS WITH BASELINE ENDOSCOPIC OR BIOMARKER EVIDENCE OF INFLAMMATION. Inflammatory bowel diseases. pp. S56-S57. [Online].